Quote | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
|Last Trade Date Time:||09/29/2023 03:00:00 am|
News | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
2023-09-12 11:00:56 ET More on AcelRx Pharmaceuticals Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals Historical earnings data for AcelRx Pharmaceuticals Financial information for AcelRx Pharmaceuticals AcelRx upgraded at HC Wainwright on likely...
2023-08-18 18:33:45 ET More on AcelRx Pharmaceuticals AcelRx Pharmaceuticals launches ~$10M private placement of shares AcelRx adds 16% on plans to divest pain therapy AcelRx announces $7.5M direct offering of common stock and warrants AcelRx Pharma rises 8% ...
Message Board Posts | AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX)
|$ACRX AcelRX Pharmaceuticals Inc||mick||investorshub||04/30/2023 10:12:48 PM|
|$ACRX AcelRX Pharmaceuticals Inc||mick||investorshub||04/15/2023 6:04:32 PM|
|Well , THAT report was ugly ..||molee||investorshub||03/31/2023 5:34:04 PM|
|Loading up .70 for events,30th ,I dont want||81vette||investorshub||03/28/2023 5:58:52 PM|
|Loading up .70 for events,30th ,I dont want||81vette||investorshub||03/28/2023 5:58:50 PM|
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
AcelRx Pharmaceuticals Inc. Website:
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 69.9% to $0.7391 in pre-market trading. The company announced the effective date for its revers...
Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE: STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maint...
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Capital raise closed in July, led by new healthcare investors; provides access to up to $26.3 million in capital, with $10 million immediately available AcelRx awaits...